Cargando…

Emerging treatments for inflammatory bowel disease

Inflammatory bowel disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), is characterized by chronic inflammation, a relapsing and remitting clinical course, requirement for lifelong medication and often, significant morbidity. While multiple effective therapeutic options exist...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hazel, Karl, O’Connor, Anthony
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003169/ https://www.ncbi.nlm.nih.gov/pubmed/32076497 http://dx.doi.org/10.1177/2040622319899297

Ejemplares similares

Current and emerging drugs for the treatment of inflammatory bowel disease
por: Triantafillidis, John K, et al.
Publicado: (2011)

Immunotherapy in inflammatory bowel disease: Novel and emerging treatments
por: Catalan-Serra, Ignacio, et al.
Publicado: (2018)

Emerging Therapies for Inflammatory Bowel Disease
por: Weisshof, Roni, et al.
Publicado: (2018)

Inflammatory Bowel Disease: Emerging Therapies and Future Treatment Strategies
por: Bretto, Elisabetta, et al.
Publicado: (2023)

Minimization of Radiation Exposure due to Computed Tomography in Inflammatory Bowel Disease
por: Mc Laughlin, Patrick D., et al.
Publicado: (2012)

Emerging Role of Exosomes in Diagnosis and Treatment of Infectious and Inflammatory Bowel Diseases
por: Larabi, Anaïs, et al.
Publicado: (2020)

Frailty in inflammatory bowel diseases: an emerging concept
por: Kochar, Bharati, et al.
Publicado: (2021)

Emerging therapeutic options in inflammatory bowel disease
por: Yamamoto-Furusho, Jesus K, et al.
Publicado: (2021)

Emerging Role of Dendritic Cell Intervention in the Treatment of Inflammatory Bowel Disease
por: Sun, Donglei, et al.
Publicado: (2022)

Novel treatments for inflammatory bowel disease
por: Lee, Hyo Sun, et al.
Publicado: (2018)

The emerging role of lncRNAs in inflammatory bowel disease
por: Yarani, Reza, et al.
Publicado: (2018)

Inflammatory Bowel Disease Treatments and Predictive Biomarkers of Therapeutic Response
por: Elhag, Duaa Ahmed, et al.
Publicado: (2022)

Biologic targeting in the treatment of inflammatory bowel diseases
por: Bosani, Matteo, et al.
Publicado: (2009)

Inflammatory bowel disease: clinical aspects and treatments
por: Fakhoury, Marc, et al.
Publicado: (2014)

New treatment options for inflammatory bowel diseases
por: Verstockt, Bram, et al.
Publicado: (2018)

Insights into the treatment of inflammatory bowel disease in pregnancy
por: Shannahan, Sarah E., et al.
Publicado: (2019)

Emerging roles of the Hedgehog signalling pathway in inflammatory bowel disease
por: Xie, Zhuo, et al.
Publicado: (2021)

The impact of sarcopenia and myosteatosis on postoperative outcomes in patients with inflammatory bowel disease
por: O’Brien, Stephen, et al.
Publicado: (2018)

Regulation of the intestinal microbiota: An emerging therapeutic strategy for inflammatory bowel disease
por: Yue, Bei, et al.
Publicado: (2020)

WSES-AAST guidelines: management of inflammatory bowel disease in the emergency setting
por: De Simone, Belinda, et al.
Publicado: (2021)

Receptor-mediated targeted drug delivery systems for treatment of inflammatory bowel disease: Opportunities and emerging strategies
por: Liu, Peng, et al.
Publicado: (2021)

The Bowel Microbiota and Inflammatory Bowel Diseases
por: Tannock, Gerald W.
Publicado: (2010)

Cannabinoids and Opioids in the Treatment of Inflammatory Bowel Diseases
por: Kienzl, Melanie, et al.
Publicado: (2020)

Vedolizumab in the treatment of inflammatory bowel disease: evolving paradigms
por: Crooks, Benjamin, et al.
Publicado: (2020)

Current status of biosimilars in the treatment of inflammatory bowel diseases
por: Park, Dong Il
Publicado: (2016)

Classical and recent advances in the treatment of inflammatory bowel diseases
por: Sales-Campos, H., et al.
Publicado: (2014)

Changing treatment paradigms for the management of inflammatory bowel disease
por: Im, Jong Pil, et al.
Publicado: (2018)

Insights on the use of biosimilars in the treatment of inflammatory bowel disease
por: Zheng, Michael K, et al.
Publicado: (2017)

The role of diet in the prevention and treatment of Inflammatory Bowel Diseases
por: Rosa, Reddavide, et al.
Publicado: (2018)

Inflammatory bowel diseases and spondyloarthropathies: From pathogenesis to treatment
por: Fragoulis, George E, et al.
Publicado: (2019)

Perspectives on Current and Novel Treatments for Inflammatory Bowel Disease
por: Na, Soo-Young, et al.
Publicado: (2019)

Selective Forms of Therapy in the Treatment of Inflammatory Bowel Diseases
por: Kofla-Dłubacz, Anna, et al.
Publicado: (2022)

Role of Biomarkers in the Diagnosis and Treatment of Inflammatory Bowel Disease
por: Wagatsuma, Kohei, et al.
Publicado: (2021)

Beyond Gene Discovery in Inflammatory Bowel Disease: The Emerging Role of Epigenetics
por: Ventham, Nicholas T., et al.
Publicado: (2013)

The Emerging Adult with Inflammatory Bowel Disease: Challenges and Recommendations for the Adult Gastroenterologist
por: Trivedi, Itishree, et al.
Publicado: (2015)

Botanical Drugs as an Emerging Strategy in Inflammatory Bowel Disease: A Review
por: Algieri, Francesca, et al.
Publicado: (2015)

Emerging role of biosimilars in the clinical care of inflammatory bowel disease patients
por: Najeeb, Hala, et al.
Publicado: (2022)

Emerging role of dual biologic therapy for the treatment of inflammatory bowel disease
por: McCormack, Matthew D, et al.
Publicado: (2023)

Emerging Comorbidities in Inflammatory Bowel Disease: Eating Disorders, Alcohol and Narcotics Misuse
por: Kuźnicki, Paweł, et al.
Publicado: (2021)

Dietary Exposures and Interventions in Inflammatory Bowel Disease: Current Evidence and Emerging Concepts
por: Gubatan, John, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qmee575dvhn8v3vli8q1hf6bfj